Synthetic Biologics, a company focused on microbiome research, presented two posters at Digestive Disease Week this year. The first poster summarizes preclinical data supporting the ability of SYN-004 ...

The poster will be available for viewing during the DDW exhibition, and details are as follows: Title: Interim PK Data for SPY001, a Novel Half-Life Extended Monoclonal Antibody Targeting α4β7 ...

“AI-Based Deconvolution of the Gut-Brain Axis and its Therapeutic Implications,” has been accepted for a poster presentation at Digestive Disease Week (DDW 2022). Invea Therapeutics is ...

at the upcoming Digestive Disease Week Conference (DDW), to be held May 3-6, 2025, in San Diego. IBSRELA is approved by the U.S. Food and Drug Administration to treat irritable bowel syndrome with ...

CINCINNATI--(BUSINESS WIRE)--CinDome Pharma, a CinRx portfolio company, will present a poster at the 2023 Digestive Disease Week (DDW) Conference, held May 6 th – 9 th in Chicago, Illinois.

Synthetic Biologics, a company focused on microbiome research, presented two posters at Digestive Disease Week this year. The posters are titled: • SYN-004, a Clinical Stage Oral Beta-Lactamase ...

SPY001 is a novel, half-life extended α4β7 antibody in development for the treatment of Inflammatory Bowel Disease (IBD) SPY001 pharmacokinetic (PK) data up to eight months continues to support ...

CINCINNATI--(BUSINESS WIRE)--CinDome Pharma, a CinRx portfolio company, will present a poster at the 2023 Digestive Disease Week (DDW) Conference, held May 6 th – 9 th in Chicago, Illinois. The poster ...